Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model

SIMPLE SUMMARY: Aspirin-triggered resolvin D1 (AT-RvD1) is biosynthesised by leukocytes as a mechanism to resolve inflammation during infection and/or injury. Emerging studies reveal that AT-RvD1 also has anti-cancer properties associated with stimulating macrophage-mediated clearance of tumour debr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannitamby, Amanda, Saad, Mohamed I., Aloe, Christian, Wang, Hao, Kumar, Beena, Vlahos, Ross, Selemidis, Stavros, Irving, Louis, Steinfort, Daniel, Jenkins, Brendan J., Bozinovski, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268479/
https://www.ncbi.nlm.nih.gov/pubmed/34203378
http://dx.doi.org/10.3390/cancers13133224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268479/
https://www.ncbi.nlm.nih.gov/pubmed/34203378
http://dx.doi.org/10.3390/cancers13133224

Ejemplares similares